Curaleaf Holdings (CURLF) EBITDA (2019 - 2026)

Curaleaf Holdings has reported EBITDA for 8 years, with the latest figure at $24.3 million in Q2 2026.

• On a quarterly basis, EBITDA fell 11.04% year-over-year to $24.3 million in Q2 2026; TTM through Jun 2026 was $39.4 million, a 7.55% increase from a year earlier, with the FY2025 full-year figure at $109.3 million, up 1.23% from the prior year.
• EBITDA was $24.3 million for Q2 2026 at Curaleaf Holdings, up from $753000.0 in the prior quarter.
• The five-year high for EBITDA was $35.1 million in Q2 2022, with the low at -$37.3 million in Q4 2022.
• Average EBITDA over 5 years is $10.9 million, with a median of $11.5 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: EBITDA sank 456.02% in 2022, then soared 276.46% in 2024.
• Over 5 years, EBITDA stood at -$37.3 million in 2022, then surged by 137.4% to $14.0 million in 2023, then plunged by 166.45% to -$9.3 million in 2024, then jumped by 211.07% to $10.3 million in 2025, then jumped by 135.59% to $24.3 million in 2026.
• The last three EBITDA figures came in at $24.3 million (Q2 2026), $753000.0 (Q1 2026), and $10.3 million (Q4 2025), per Business Quant data.